Capital World Investors
CLBT icon

Capital World Investors’s Cellebrite CLBT Stock Holding History

Capital World Investors’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.8M Buy
2,112,733
+1,897,225
+880% +$25.1M ﹤0.01% 522
2026
Q1 		$2.97M Buy
+215,508
New +$3.25M ﹤0.01% 583

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Capital World Investors's CLBT Position: Q2 2026 in Review

Capital World Investors increased its Cellebrite (CLBT) stake by 880% in Q2 2026, buying an estimated $25.1M and bringing the position to 2,112,733 shares worth $30.8M. The position accounts for ﹤0.01% of the portfolio, ranked #522.

Capital World Investors first reported a position in CLBT in Q1 2026 and has held it in 2 quarters since. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Capital World Investors held 2,112,733 shares of Cellebrite worth $30.8M as of Q2 2026.
  • Capital World Investors bought 1,897,225 Cellebrite shares in Q2 2026, an estimated $25.1M.
  • Cellebrite made up ﹤0.01% of Capital World Investors's portfolio in Q2 2026, its #522 holding.
  • Capital World Investors first reported a position in Cellebrite in Q1 2026 and has held it in 2 quarters since.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Capital World Investors's 13F filing for Q2 2026, filed 12 Aug 2026.